Compare OI & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OI | TXG |
|---|---|---|
| Founded | 1903 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.8B |
| IPO Year | 1994 | 2019 |
| Metric | OI | TXG |
|---|---|---|
| Price | $12.19 | $22.51 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 14 |
| Target Price | ★ $17.57 | $17.18 |
| AVG Volume (30 Days) | 1.8M | ★ 2.6M |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,426,000,000.00 | $245,893,000.00 |
| Revenue This Year | $3.21 | N/A |
| Revenue Next Year | $1.82 | $7.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $9.23 | $6.78 |
| 52 Week High | $16.91 | $23.56 |
| Indicator | OI | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 27.92 | 64.06 |
| Support Level | $11.17 | $11.62 |
| Resistance Level | $13.54 | $23.56 |
| Average True Range (ATR) | 0.59 | 1.48 |
| MACD | -0.31 | 0.43 |
| Stochastic Oscillator | 1.14 | 86.59 |
O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).